Routinely collected data for randomized trials: Promises, barriers, and implications

Trials

Volumn 19, Issue 1, 2018, Pages

  Mc Cord, Kimberly A ^a   Al Shahi Salman, Rustam ^b   Treweek, Shaun ^c   Gardner, Heidi ^c   Strech, Daniel ^d   Whiteley, William ^b   Ioannidis, John P A ^e,f   Hemkens, Lars G ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Clinical epidemiology; Electronic health records; Evidence based medicine; Registries; Routinely collected health data; Trials

Indexed keywords

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; ELECTRONIC HEALTH RECORD; EXTERNAL VALIDITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICINE; OUTCOME ASSESSMENT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REGISTER; SAMPLE SIZE; SINGLE BLIND PROCEDURE; VALIDATION PROCESS; ECONOMICS; INFORMATION PROCESSING; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS;

DATA COLLECTION; ETHICS, RESEARCH; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85040310210     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-2394-5     Document Type: Review

References (42)

1. Lauer MS, D'Agostino RBS. The randomized registry trial-the next disruptive technology in clinical research? N Engl J Med. 2013;369(17):1579-81.
2. Mathes T, Buehn S, Prengel P, Pieper D. Registry-based randomized controlled trials merged the strength of randomized controlled trials and observational studies and give rise to more pragmatic trials. J Clin Epidemiol. doi: https://doi.org/10.1016/j.jclinepi.2017.09.017.
3. Lund LH, Oldgren J, James S. Registry-based pragmatic trials in heart failure: current experience and future directions. Curr Heart Fail Rep. 2017;14(2):59-70.
4. Li G, Sajobi TT, Menon BK, et al. Registry-based randomized controlled trials - what are the advantages, challenges, and areas for future research? J Clin Epidemiol. 2016;80(Suppl C):16-24.
5. Choudhry NK. Randomized, controlled trials in health insurance systems. N Engl J Med. 2017;377(10):957-64.
6. Zuidgeest MGP, Goetz I, Groenwold RHH, Irving E, van Thiel G, Grobbee DE. Series: Pragmatic trials and real world evidence. Paper 1: Introduction. J Clin Epidemiol. 2017;88:7-13.
7. Meinecke AK, Welsing P, Kafatos G, Burke D, Trelle S, Kubin M, Nachbaur G, Egger M, Zuidgeest M. work package 3 of the GetReal consortium. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management. J Clin Epidemiol. 2017;91:13-22. doi: https://doi.org/10.1016/j.jclinepi.2017.07.003.
8. Kim SY, Miller FG. Informed consent for pragmatic trials-the integrated consent model. N Engl J Med. 2014;370(8):769-72.
9. Ioannidis JP. Why most clinical research is not useful. PLoS Med. 2016;13(6):e1002049.
10. Hemkens LG, Contopoulos-Ioannidis DG, Ioannidis JP. Routinely collected data and comparative effectiveness evidence: promises and limitations. CMAJ. 2016;188(8):E158-64.
11. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32.
12. Kasenda B, von Elm EB, You J, et al. Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study). BMC Med Res Methodol. 2012;12:131.
13. Rao JN, Cassia LJS. Ethics of undisclosed payments to doctors recruiting patients in clinical trials. BMJ. 2002;325(7354):36-7.
14. Aung T, Haynes R, Barton J, et al. Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND). Trials. 2016;17(1):286.
15. Gliklich RE, Dreyer NA, Leavy MB. Rare disease registries. In: Registries for evaluating patient outcomes: a user's guide. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2014. p. 113-25.
16. Sertkaya A, Wong HH, Jessup A, Beleche T. Key cost drivers of pharmaceutical clinical trials in the United States. Clin Trials. 2016;13(2):117-26.
17. Bargaje C. Good documentation practice in clinical research. Perspect Clin Res. 2011;2(2):59-63.
18. van Engelen B. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial. Trials. 2015;16:224.
19. Ioannidis JA. Mega-trials for blockbusters. JAMA. 2013;309(3):239-40.
20. Ramsberg J, Neovius M. Register or electronic health records enriched randomized pragmatic trials: the future of clinical effectiveness and cost-effectiveness trials? Nordic J Health Econ. 2015;3(1):1-15. doi: https://doi.org/10.5617/njhe.1386.
21. Antman EM, Bierer BE. Standards for clinical research: keeping pace with the technology of the future. Circulation. 2016;133(9):823-5.
22. Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18(1):122.
23. Hemkens LG, Contopoulos-Ioannidis DG, Ioannidis JP. Concordance of effects of medical interventions on hospital admission and readmission rates with effects on mortality. CMAJ. 2013;185(18):E827-37.
24. Jensen RE, Snyder CF, Abernethy AP, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014;10(4):e215-22.
25. Hemkens LG, Saccilotto R, Reyes SL, et al. Personalized prescription feedback using routinely collected data to reduce antibiotic use in primary care: a randomized clinical trial. JAMA Intern Med. 2017;177(2):176-83.
26. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357(15):1477-86.
27. Schmidt C. Cancer: reshaping the cancer clinic. Nature. 2015;527(7576):S10-1.
28. World Medical Association (WMA). Declaration of Taipei on ethical considerations regarding health databases and biobanks. 2016. https://www.wma.net/policies-post/wma-declaration-of-taipei-on-ethical-considerations-regarding-health-databases-and-biobanks/. Accessed 23 Dec 2017.
29. Nuffield Council on Bioethics. The collection, linking and use of data in biomedical research and health care: ethical issues. London: Nuffield Council on Bioethics; 2015. http://nuffieldbioethics.org/project/biological-health-data/.
30. Faden R, Kass N, Whicher D, Stewart W, Tunis S. Ethics and informed consent for comparative effectiveness research with prospective electronic clinical data. Med Care. 2013;51(8 Suppl 3):S53-7.
31. Nayak RK, Wendler D, Miller FG, Kim SY. Pragmatic randomized trials without standard informed consent? A national survey. Ann Intern Med. 2015;163(5):356-64.
32. Cho MK, Magnus D, Constantine M, et al. Attitudes toward risk and informed consent for research on medical practices: a cross-sectional survey. Ann Intern Med. 2015;162(10):690-6.
33. Strech D, Bein S, Brumhard M, et al. A template for broad consent in biobank research: results and explanation of an evidence and consensus-based development process. Eur J Med Genet. 2016;59(6-7):295-309.
34. Beskow LM, Friedman JY, Hardy NC, Lin L, Weinfurt KP. Developing a simplified consent form for biobanking. PLoS One. 2010;5(10):e13302.
35. Lasko TA, Vinterbo SA. Spectral anonymization of data. IEEE Trans Knowl Data Eng. 2010;22(3):437-46.
36. Califf RM, Sanderson I, Miranda ML. The future of cardiovascular clinical research: informatics, clinical investigators, and community engagement. JAMA. 2012;308(17):1747-8.
37. Bhise V, Meyer AND, Singh H, et al. Errors in diagnosis of spinal epidural abscesses in the era of electronic health records. Am J Med. 2017;130(8):975-81.
38. Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.
39. Jacob C, Meise D, Mittendorf T, Braun S. The use of real world evidence to support market access of medical devices - implications for the German setting [abstract]. Value Health. 2015;18(7):A372.
40. Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587-97.
41. Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish healthcare quality registries. J Intern Med. 2015;277(1):94-136.
42. Bohm ER, Dunbar MJ, Bourne R. The Canadian Joint Replacement Registry-what have we learned? Acta Orthop. 2010;81(1):119-21.